L Caspary|A Creutzig - JoVE Visualize

Showing results (1-10 of 87) with videos related to

Pageof 9

Sort By:

Therapie|May 1, 1991

Prostanoids in therapy of peripheral arterial occlusive diseaseA Creutzig, L Caspary

Advances in Experimental Medicine and Biology|January 1, 1987

Comparison of Laser-Doppler-Flux and tcPO2 in healthy probands and patients with arterial ischemiaL Caspary, A Creutzig, K Alexander

VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1993

Variability of TcPO2-measurements at 37 degrees C and 44 degrees C in patients with claudication in consideration of provocation testsL Caspary, A Creutzig, K Alexander

VASA. Zeitschrift Fur Gefasskrankheiten|August 1, 1997

Changes of dermal haemoglobin oxygenation and concentration in healthy subjects and in patients with peripheral arterial occlusive disease during and after acute ischemiaJ Thum, L Caspary, A Creutzig

European Journal of Clinical Pharmacology|January 1, 1991

Intravenous infusion of iloprost in arterial occlusive disease: dose-dependent effects on skin microcirculationL Caspary, A Creutzig, K Alexander

Klinische Wochenschrift|February 15, 1990

Skin surface oxygen pressure fields during administration of prostaglandin E1 in patients with arterial occlusive diseaseA Creutzig, L Caspary, K Alexander

International Journal of Microcirculation, Clinical and Experimental|August 1, 1991

Skin surface oxygen pressure in healthy volunteers and patients with arterial occlusive diseaseA Creutzig, L Caspary, K Alexander

Medizinische Klinik (Munich, Germany : 1983)|November 15, 1995

[How often is thrombolytic therapy of deep pelvic-leg venous thrombosis indicated?]L Caspary, A Creutzig, K Alexander

VASA. Zeitschrift Fur Gefasskrankheiten|August 1, 1997

Circadian variation of skin perfusion in arterial occlusive diseaseL Caspary, S Nordbruch, R Lange, et al.

International Journal of Microcirculation, Clinical and Experimental|July 1, 1997

Vital capillary microscopy of skin areas at the forefoot of diabetic patients using intraarterial injection of Na-fluoresceinM Meier, L Caspary, A Creutzig, et al.

Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:

Pageof 9

Therapie|May 1, 1991

Prostanoids in therapy of peripheral arterial occlusive diseaseA Creutzig, L Caspary

Advances in Experimental Medicine and Biology|January 1, 1987

Comparison of Laser-Doppler-Flux and tcPO2 in healthy probands and patients with arterial ischemiaL Caspary, A Creutzig, K Alexander

VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1993

Variability of TcPO2-measurements at 37 degrees C and 44 degrees C in patients with claudication in consideration of provocation testsL Caspary, A Creutzig, K Alexander

VASA. Zeitschrift Fur Gefasskrankheiten|August 1, 1997

Changes of dermal haemoglobin oxygenation and concentration in healthy subjects and in patients with peripheral arterial occlusive disease during and after acute ischemiaJ Thum, L Caspary, A Creutzig

European Journal of Clinical Pharmacology|January 1, 1991

Intravenous infusion of iloprost in arterial occlusive disease: dose-dependent effects on skin microcirculationL Caspary, A Creutzig, K Alexander

Klinische Wochenschrift|February 15, 1990

Skin surface oxygen pressure fields during administration of prostaglandin E1 in patients with arterial occlusive diseaseA Creutzig, L Caspary, K Alexander

International Journal of Microcirculation, Clinical and Experimental|August 1, 1991

Skin surface oxygen pressure in healthy volunteers and patients with arterial occlusive diseaseA Creutzig, L Caspary, K Alexander

Medizinische Klinik (Munich, Germany : 1983)|November 15, 1995

[How often is thrombolytic therapy of deep pelvic-leg venous thrombosis indicated?]L Caspary, A Creutzig, K Alexander

VASA. Zeitschrift Fur Gefasskrankheiten|August 1, 1997

Circadian variation of skin perfusion in arterial occlusive diseaseL Caspary, S Nordbruch, R Lange, et al.

International Journal of Microcirculation, Clinical and Experimental|July 1, 1997

Vital capillary microscopy of skin areas at the forefoot of diabetic patients using intraarterial injection of Na-fluoresceinM Meier, L Caspary, A Creutzig, et al.

Pageof 9